Multifunctional Abl kinases in health and disease

Journal of Cell Science

Volumn 129, Issue 1, 2016, Pages 9-16

  Khatri, Aaditya ^a   Wang, Jun ^a   Pendergast, Ann Marie ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abelson kinases; Adhesion; Cancer; Cell motility; Cytoskeletal reorganization; Endocytosis; Inflammation; Microbial pathogens; Polarity

Indexed keywords

ABELSON KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL JUNCTION; CELL MIGRATION; CELL MOTILITY; CELL ORGANELLE; CELL POLARITY; CELL PROLIFERATION; CELL SURVIVAL; DEGENERATIVE DISEASE; HEALTH; HUMAN; INFLAMMATION; KIDNEY CARCINOMA; LEIOMYOMATOSIS; LEUKEMIA; NONHUMAN; PATHOGENESIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SOLID TUMOR; ANIMAL; CHEMISTRY; CYTOSKELETON; DISEASES; METABOLISM;

ANIMALS; CELL SURVIVAL; CYTOSKELETON; DISEASE; HEALTH; HUMANS; PROTO-ONCOGENE PROTEINS C-ABL; SIGNAL TRANSDUCTION;

EID: 84959019886     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.175521     Document Type: Article

References (119)

1. Abelson, H. T. and Rabstein, L. S. (1970). Lymphosarcoma: virus-induced thymicindependent disease in mice. Cancer Res. 30, 2213-2222.
2. Aleem, S. U., Craddock, B. P. and Miller, W. T. (2015). Constitutive activity in an ancestral form of Abl tyrosine kinase. PLoS ONE 10, e0131062.
3. Balaji, K., Mooser, C., Janson, C. M., Bliss, J. M., Hojjat, H. and Colicelli, J. (2012). RIN1 orchestrates the activation of RAB5 GTPases and ABL tyrosine kinases to determine the fate of EGFR. J. Cell Sci. 125, 5887-5896.
4. Bauer, B., Bartfeld, S. and Meyer, T. F. (2009). H. pylori selectively blocks EGFR endocytosis via the non-receptor kinase c-Abl and CagA. Cell Microbiol. 11, 156-169.
5. Bays, J. L., Peng, X., Tolbert, C. E., Guilluy, C., Angell, A. E., Pan, Y., Superfine, R., Burridge, K. and DeMali, K. A. (2014). Vinculin phosphorylation differentially regulates mechanotransduction at cell-cell and cell-matrix adhesions. J. Cell Biol. 205, 251-263.
6. Bianchi, C., Torsello, B., Angeloni, V., Bombelli, S., Soldi, M., Invernizzi, L., Brambilla, P. and Perego, R. A. (2008). Eight full-length abelson related gene (Arg) isoforms are constitutively expressed in caki-1 cell line and cell distribution of two isoforms has been analyzed after transfection. J. Cell Biochem. 105, 1219-1227.
7. Boureux, A., Furstoss, O., Simon, V. and Roche, S. (2005). Abl tyrosine kinase regulates a Rac/JNK and a Rac/Nox pathway for DNA synthesis and Myc expression induced by growth factors. J. Cell Sci. 118, 3717-3726.
8. Boyle, S. N., Michaud, G. A., Schweitzer, B., Predki, P. F. and Koleske, A. J. (2007). A critical role for cortactin phosphorylation by Abl-family kinases in PDGFinduced dorsal-wave formation. Curr. Biol. 17, 445-451.
9. Bradley, W. D. and Koleske, A. J. (2009). Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts. J. Cell Sci. 122, 3441-3454.
10. Bruns, H., Stegelmann, F., Fabri, M., Dohner, K., van Zandbergen, G., Wagner, M., Skinner, M., Modlin, R. L. and Stenger, S. (2012). Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophages. J. Immunol. 189, 4069-4078.
11. Burton, E. A., Plattner, R. and Pendergast, A. M. (2003). Abl tyrosine kinases are required for infection by Shigella flexneri. EMBO J. 22, 5471-5479.
12. Burton, E. A., Oliver, T. N. and Pendergast, A. M. (2005). Abl kinases regulate actin comet tail elongation via an N-WASP-dependent pathway. Mol. Cell. Biol. 25, 8834-8843.
13. Cancino, G. I., Toledo, E. M., Leal, N. R., Hernandez, D. E., Yevenes, L. F., Inestrosa, N. C. and Alvarez, A. R. (2008). STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's betaamyloid deposits. Brain 131, 2425-2442.
14. Chen, T. -C., Lai, Y. -K., Yu, C. -K. and Juang, J. -L. (2007). Enterovirus 71 triggering of neuronal apoptosis through activation of Abl-Cdk5 signalling. Cell Microbiol. 9, 2676-2688.
15. Chen, P. -I., Kong, C., Su, X. and Stahl, P. D. (2009). Rab5 isoforms differentially regulate the trafficking and degradation of epidermal growth factor receptors. J. Biol. Chem. 284, 30328-30338.
16. Chevalier, C., Cannet, A., Descamps, S., Sirvent, A., Simon, V., Roche, S. and Benistant, C. (2015). ABL tyrosine kinase inhibition variable effects on the invasive properties of different triple negative breast cancer cell lines. PLoS ONE 10, e0118854.
17. Chislock, E. M. and Pendergast, A. M. (2013). Abl family kinases regulate endothelial barrier function in vitro and in mice. PLoS ONE 8, e85231.
18. Chislock, E. M., Ring, C. and Pendergast, A. M. (2013). Abl kinases are required for vascular function, Tie2 expression, and angiopoietin-1-mediated survival. Proc. Natl. Acad. Sci. USA 110, 12432-12437.
19. Colicelli, J. (2010). ABL tyrosine kinases: evolution of function, regulation, and specificity. Sci. Signal. 3, re6.
20. Coyne, C. B. and Bergelson, J. M. (2006). Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124, 119-131.
21. De Braekeleer, E., Douet-Guilbert, N., Morel, F., Le Bris, M. -J., Basinko, A. and De Braekeleer, M. (2012). ETV6 fusion genes in hematological malignancies: a review. Leuk. Res. 36, 945-961.
22. Dunn, D. M., Woodford, M. R., Truman, A. W., Jensen, S. M., Schulman, J., Caza, T., Remillard, T. C., Loiselle, D., Wolfgeher, D., Blagg, B. S. J. et al. (2015). c-Abl mediated tyrosine phosphorylation of Aha1 activates its co-chaperone function in cancer cells. Cell Rep. 12, 1006-1018.
23. Echarri, A., Muriel, O., Pavon, D. M., Azegrouz, H., Escolar, F., Terron, M. C., Sanchez-Cabo, F., Martinez, F., Montoya, M. C., Llorca, O. et al. (2012). Caveolar domain organization and trafficking is regulated by Abl kinases and mDia1. J. Cell Sci. 125, 3097-3113.
24. Eide, C. A. and O'Hare, T. (2015). Chronic myeloid leukemia: advances in understanding disease biology and mechanisms of resistance to tyrosine kinase inhibitors. Curr. Hematol. Malig. Rep. 10, 158-166.
25. Elwell, C. A., Ceesay, A., Kim, J. H., Kalman, D. and Engel, J. N. (2008). RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog. 4, e1000021.
26. Esparza-Lopez, J., Medina-Franco, H., Escobar-Arriaga, E., Leon-Rodriguez, E., Zentella-Dehesa, A. and Ibarra-Sanchez, M. J. (2013). Doxorubicin induces atypical NF-kappaB activation through c-Abl kinase activity in breast cancer cells. J. Cancer Res. Clin. Oncol. 139, 1625-1635.
27. Finn, A. J., Feng, G. and Pendergast, A. M. (2003). Postsynaptic requirement for Abl kinases in assembly of the neuromuscular junction. Nat. Neurosci. 6, 717-723.
28. Fiore, L. S., Ganguly, S. S., Sledziona, J., Cibull, M. L., Wang, C., Richards, D. L., Neltner, J. M., Beach, C., McCorkle, J. R., Kaetzel, D. M. et al. (2014). c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer. Oncogene 33, 4508-4520.
29. Furstoss, O., Dorey, K., Simon, V., Barila, D., Superti-Furga, G. and Roche, S. (2002). c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis. EMBO J. 21, 514-524.
30. Gaki, G. S. and Papavassiliou, A. G. (2014). Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease. Neuromol. Med. 16, 217-230.
31. Garcia, M., Cooper, A., Shi, W., Bornmann, W., Carrion, R., Kalman, D. and Nabel, G. J. (2012). Productive replication of Ebola virus is regulated by the c-Abl1 tyrosine kinase. Sci. Transl. Med. 4, 123ra24.
32. Genander, M., Halford, M. M., Xu, N. -J., Eriksson, M., Yu, Z., Qiu, Z., Martling, A., Greicius, G., Thakar, S., Catchpole, T. et al. (2009). Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression. Cell 139, 679-692.
33. Gil-Henn, H., Patsialou, A., Wang, Y., Warren, M., Condeelis, J. and Koleske, A. (2013). Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo. Oncogene 32, 2622-2630.
34. Goedert, M. (2001). Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2, 492-501.
35. Goff, S. P., Gilboa, E., Witte, O. N. and Baltimore, D. (1980). Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell 22, 777-785.
36. Gourley, S. L., Koleske, A. J. and Taylor, J. R. (2009). Loss of dendrite stabilization by the Abl-related gene (Arg) kinase regulates behavioral flexibility and sensitivity to cocaine. Proc. Natl. Acad. Sci. USA 106, 16859-16864.
37. Greuber, E. K. and Pendergast, A. M. (2012). Abl family kinases regulate FcγRmediated phagocytosis in murine macrophages. J. Immunol. 189, 5382-5392.
38. Greuber, E. K., Smith-Pearson, P., Wang, J. and Pendergast, A. M. (2013). Role of ABL family kinases in cancer: from leukaemia to solid tumours. Nat. Rev. Cancer 13, 559-571.
39. Gu, J. J., Zhang, N., He, Y. -W., Koleske, A. J. and Pendergast, A. M. (2007). Defective T cell development and function in the absence of Abelson kinases. J. Immunol. 179, 7334-7343.
40. Gu, J. J., Lavau, C. P., Pugacheva, E., Soderblom, E. J., Moseley, M. A. and Pendergast, A. M. (2012). Abl family kinases modulate T cell-mediated inflammation and chemokine-induced migration through the adaptor HEF1 and the GTPase Rap1. Sci. Signal. 5, ra51.
41. Hantschel, O. and Superti-Furga, G. (2004). Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat. Rev. Mol. Cell Biol. 5, 33-44.
42. Harmon, B., Campbell, N. and Ratner, L. (2010). Role of Abl kinase and theWave2 signaling complex in HIV-1 entry at a post-hemifusion step. PLoS Pathog. 6, e1000956.
43. Hu, H., Bliss, J. M., Wang, Y. and Colicelli, J. (2005). RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration. Curr. Biol. 15, 815-823.
44. Imam, S. Z., Zhou, Q., Yamamoto, A., Valente, A. J., Ali, S. F., Bains, M., Roberts, J. L., Kahle, P. J., Clark, R. A. and Li, S. (2011). Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease. J. Neurosci. 31, 157-163.
45. Jacob, M., Todd, L. A., Majumdar, R. S., Li, Y., Yamamoto, K. -I. and Pure, E. (2009). Endogenous cAbl regulates receptor endocytosis. Cell Signal. 21, 1308-1316.
46. Jayaswal, S., Kamal, M. A., Dua, R., Gupta, S., Majumdar, T., Das, G., Kumar, D. and Rao, K. V. S. (2010). Identification of host-dependent survival factors for intracellular Mycobacterium tuberculosis through an siRNA screen. PLoS Pathog. 6, e1000839.
47. Jing, Z., Caltagarone, J. and Bowser, R. (2009). Altered subcellular distribution of c-Abl in Alzheimer's disease. J. Alzheimers Dis. 17, 409-422.
48. Karuppagounder, S. S., Brahmachari, S., Lee, Y., Dawson, V. L., Dawson, T. M. and Ko, H. S. (2014). The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease. Sci. Rep. 4, 4874.
49. Ko, H. S., Lee, Y., Shin, J. -H., Karuppagounder, S. S., Gadad, B. S., Koleske, A. J., Pletnikova, O., Troncoso, J. C., Dawson, V. L. and Dawson, T. M. (2010). Phosphorylation by the c-Abl protein tyrosine kinase inhibits Parkin's ubiquitination and protective function. Proc. Natl. Acad. Sci. USA 107, 16691-16696.
50. Koleske, A. J., Gifford, A. M., Scott, M. L., Nee, M., Bronson, R. T., Miczek, K. A. and Baltimore, D. (1998). Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21, 1259-1272.
51. Kruh, G. D., Perego, R., Miki, T. and Aaronson, S. A. (1990). The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc. Natl. Acad. Sci. USA 87, 5802-5806.
52. Kua, H. -Y., Liu, H., Leong, W. F., Li, L., Jia, D., Ma, G., Hu, Y., Wang, X., Chau, J. F. L., Chen, Y. -G. et al. (2012). c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression. Nat. Cell Biol. 14, 727-737.
53. Kundu, P., Genander, M., Straat, K., Classon, J., Ridgway, R. A., Tan, E. H., Bjork, J., Martling, A., van Es, J., Sansom, O. J. et al. (2015). An EphB-Abl signaling pathway is associated with intestinal tumor initiation and growth. Sci. Transl. Med. 7, 281ra44.
54. Lechler, T. and Fuchs, E. (2005). Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature 437, 275-280.
55. Lee, J. -H., Jeong, M. -W., Kim, W., Choi, Y. H. and Kim, K. -T. (2008). Cooperative roles of c-Abl and Cdk5 in regulation of p53 in response to oxidative stress. J. Biol. Chem. 283, 19826-19835.
56. Li, B. (2005). c-Abl in oxidative stress, aging and cancer. Cell Cycle 4, 246-248.
57. Li, R. and Pendergast, A. M. (2011). Arg kinase regulates epithelial cell polarity by targeting beta1-integrin and small GTPase pathways. Curr. Biol. 21, 1534-1542.
58. Li, B., Boast, S., de los Santos, K., Schieren, I., Quiroz, M., Teitelbaum, S. L., Tondravi, M. M. and Goff, S. P. (2000). Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat. Genet. 24, 304-308.
59. Li, R., Knight, J. F., Park, M. and Pendergast, A. M. (2015). Abl kinases regulate HGF/Met signaling required for epithelial cell scattering, tubulogenesis and motility. PLoS ONE 10, e0124960.
60. Liberatore, R. A. and Goff, S. P. (2009). c-Abl-deficient mice exhibit reduced numbers of peritoneal B-1 cells and defects in BCR-induced B cell activation. Int. Immunol. 21, 403-414.
61. Lin, M., den Dulk-Ras, A., Hooykaas, P. J. J. and Rikihisa, Y. (2007). Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection. Cell Microbiol. 9, 2644-2657.
62. Lo, Y. H., Ho, P. C., Zhao, H. andWang, S. C. (2011). Inhibition of c-ABL sensitizes breast cancer cells to the dual ErbB receptor tyrosine kinase inhibitor lapatinib (GW572016). Anticancer Res. 31, 789-795.
63. Lonskaya, I., Hebron, M. L., Desforges, N. M., Franjie, A. and Moussa, C. E. -H. (2013a). Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance. EMBO Mol. Med. 5, 1247-1262.
64. Lonskaya, I., Hebron, M. L., Algarzae, N. K., Desforges, N. and Moussa, C. E. -H. (2013b). Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson's disease. Neuroscience 232, 90-105.
65. Lonskaya, I., Hebron, M. L., Selby, S. T., Turner, R. S. and Moussa, C. E. -H. (2015). Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimer's disease models. Neuroscience 304, 316-327.
66. Lorenz, S., Deng, P., Hantschel, O., Superti-Furga, G. and Kuriyan, J. (2015). Crystal structure of an SH2-kinase construct of c-Abl and effect of the SH2 domain on kinase activity. Biochem. J. 468, 283-291.
67. Ly, K. T. and Casanova, J. E. (2009). Abelson tyrosine kinase facilitates Salmonella enterica serovar Typhimurium entry into epithelial cells. Infect. Immun. 77, 60-69.
68. Mader, C. C., Oser, M., Magalhaes, M. A. O., Bravo-Cordero, J. J., Condeelis, J., Koleske, A. J. and Gil-Henn, H. (2011). An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. Cancer Res. 71, 1730-1741.
69. Mahul-Mellier, A. -L., Fauvet, B., Gysbers, A., Dikiy, I., Oueslati, A., Georgeon, S., Lamontanara, A. J., Bisquertt, A., Eliezer, D., Masliah, E. et al. (2014). c-Abl phosphorylates alpha-synuclein and regulates its degradation: implication for alpha-synuclein clearance and contribution to the pathogenesis of Parkinson's disease. Hum. Mol. Genet. 23, 2858-2879.
70. Matsumura, S., Hamasaki, M., Yamamoto, T., Ebisuya, M., Sato, M., Nishida, E. and Toyoshima, F. (2012). ABL1 regulates spindle orientation in adherent cells and mammalian skin. Nat. Commun. 3, 626.
71. Miller, A. L., Wang, Y., Mooseker, M. S. and Koleske, A. J. (2004). The Abl-related gene (Arg) requires its F-actin-microtubule cross-linking activity to regulate lamellipodial dynamics during fibroblast adhesion. J. Cell Biol. 165, 407-419.
72. Moresco, E. M. Y., Donaldson, S., Williamson, A. and Koleske, A. J. (2005). Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases. J. Neurosci. 25, 6105-6118.
73. Muller, A. (2012). Multistep activation of the Helicobacter pylori effector CagA. J. Clin. Invest. 122, 1192-1195.
74. Nagar, B., Hantschel, O., Young, M. A., Scheffzek, K., Veach, D., Bornmann, W., Clarkson, B., Superti-Furga, G. and Kuriyan, J. (2003). Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112, 859-871.
75. Nagar, B., Hantschel, O., Seeliger, M., Davies, J. M., Weis, W. I., Superti-Furga, G. and Kuriyan, J. (2006). Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. Mol. Cell 21, 787-798.
76. Napier, R. J., Rafi, W., Cheruvu, M., Powell, K. R., Zaunbrecher, M. A., Bornmann, W., Salgame, P., Shinnick, T. M. and Kalman, D. (2011). Imatinibsensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis. Cell Host Microbe 10, 475-485.
77. Newsome, T. P., Weisswange, I., Frischknecht, F. and Way, M. (2006). Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus. Cell Microbiol. 8, 233-241.
78. Pielage, J. F., Powell, K. R., Kalman, D. and Engel, J. N. (2008). RNAi screen reveals an Abl kinase-dependent host cell pathway involved in Pseudomonas aeruginosa internalization. PLoS Pathog. 4, e1000031.
79. Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A. and Pendergast, A. M. (1999). c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13, 2400-2411.
80. Plattner, R., Irvin, B. J., Guo, S., Blackburn, K., Kazlauskas, A., Abraham, R. T., York, J. D. and Pendergast, A. M. (2003). A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-gamma1. Nat. Cell Biol. 5, 309-319.
81. Poppe, M., Feller, S. M., Römer, G. and Wessler, S. (2007). Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene 26, 3462-3472.
82. Raimondi, C. (2014). Neuropilin-1 enforces extracellular matrix signalling via ABL1 to promote angiogenesis. Biochem. Soc. Trans. 42, 1429-1434.
83. Raimondi, C., Fantin, A., Lampropoulou, A., Denti, L., Chikh, A. and Ruhrberg, C. (2014). Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells. J. Exp. Med. 211, 1167-1183.
84. Reeves, P. M., Bommarius, B., Lebeis, S., McNulty, S., Christensen, J., Swimm, A., Chahroudi, A., Chavan, R., Feinberg, M. B., Veach, D. et al. (2005). Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nat. Med. 11, 731-739.
85. Salah, E., Ugochukwu, E., Barr, A. J., von Delft, F., Knapp, S. and Elkins, J. M. (2011). Crystal structures of ABL-related gene (ABL2) in complex with imatinib, tozasertib (VX-680), and a type I inhibitor of the triazole carbothioamide class. J. Med. Chem. 54, 2359-2367.
86. Schlatterer, S. D., Acker, C. M. and Davies, P. (2011). c-Abl in neurodegenerative disease. J. Mol. Neurosci. 45, 445-452.
87. Schwartzberg, P. L., Stall, A. M., Hardin, J. D., Bowdish, K. S., Humaran, T., Boast, S., Harbison, M. L., Robertson, E. J. and Goff, S. P. (1991). Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65, 1165-1175.
88. Simpson, M. A., Bradley, W. D., Harburger, D., Parsons, M., Calderwood, D. A. and Koleske, A. J. (2015). Direct interactions with the integrin beta1 cytoplasmic tail activate the Abl2/Arg kinase. J. Biol. Chem. 290, 8360-8372.
89. Sims, J. T., Ganguly, S. S., Bennett, H., Friend, J. W., Tepe, J. and Plattner, R. (2013). Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-kappaB and HSP27/p38/AKT pathways and by inhibiting ABCB1. PLoS ONE 8, e55509.
90. Sini, P., Cannas, A., Koleske, A. J., Di Fiore, P. P. and Scita, G. (2004). Abldependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation. Nat. Cell Biol. 6, 268-274.
91. Sirvent, A., Benistant, C. and Roche, S. (2008). Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells. Biol. Cell 100, 617-631.
92. Smith-Pearson, P. S., Greuber, E. K., Yogalingam, G. and Pendergast, A. M. (2010). Abl kinases are required for invadopodia formation and chemokineinduced invasion. J. Biol. Chem. 285, 40201-40211.
93. Sonoshita, M., Itatani, Y., Kakizaki, F., Sakimura, K., Terashima, T., Katsuyama, Y., Sakai, Y. and Taketo, M. M. (2015). Promotion of colorectal cancer invasion and metastasis through activation of NOTCH-DAB1-ABL-RHOGEF protein TRIO. Cancer Discov. 5, 198-211.
94. Sossey-Alaoui, K., Li, X. and Cowell, J. K. (2007). c-Abl-mediated phosphorylation of WAVE3 is required for lamellipodia formation and cell migration. J. Biol. Chem. 282, 26257-26265.
95. Sourbier, C., Ricketts, C. J., Matsumoto, S., Crooks, D. R., Liao, P. -J., Mannes, P. Z., Yang, Y., Wei, M. -H., Srivastava, G., Ghosh, S. et al. (2014). Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer. Cancer Cell 26, 840-850.
96. Stuart, J. R., Gonzalez, F. H., Kawai, H. and Yuan, Z. -M. (2006). c-Abl interacts with the WAVE2 signaling complex to induce membrane ruffling and cell spreading. J. Biol. Chem. 281, 31290-31297.
97. Stuhlmiller, T. J., Miller, S. M., Zawistowski, J. S., Nakamura, K., Beltran, A. S., Duncan, J. S., Angus, S. P., Collins, K. A. L., Granger, D. A., Reuther, R. A. et al. (2015). Inhibition of lapatinib-induced kinome reprogramming in ERBB2-positive breast cancer by targeting BET family bromodomains. Cell Rep. 11, 390-404.
98. Swimm, A., Bommarius, B., Li, Y., Cheng, D., Reeves, P., Sherman, M., Veach, D., Bornmann, W. and Kalman, D. (2004). Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals. Mol. Biol. Cell 15, 3520-3529.
99. Tammer, I., Brandt, S., Hartig, R., König, W. and Backert, S. (2007). Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology 132, 1309-1319.
100. Tanabe, A., Yamamura, Y., Kasahara, J., Morigaki, R., Kaji, R. and Goto, S. (2014). A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson's disease. Front. Cell Neurosci. 8, 50.
101. Tanos, B. and Pendergast, A. M. (2006). Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor. J. Biol. Chem. 281, 32714-32723.
102. Tanos, B. E. and Pendergast, A. M. (2007). Abi-1 forms an epidermal growth factorinducible complex with Cbl: role in receptor endocytosis. Cell Signal. 19, 1602-1609.
103. Trampont, P. C., Zhang, L., Giles, A. J., Walk, S. F., Gu, J. J., Pendergast, A. M. and Ravichandran, K. S. (2015). ShcA regulates thymocyte proliferation through specific transcription factors and a c-Abl-dependent signaling axis. Mol. Cell. Biol. 35, 1462-1476.
104. Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T. and Mulligan, R. C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163.
105. Wang, J. Y. J. (2014). The capable ABL: what is its biological function? Mol. Cell. Biol. 34, 1188-1197.
106. Wang, Y. -L., Overstreet, A. -M., Chen, M. -S., Wang, J., Zhao, H. -J., Ho, P. -C., Smith, M. and Wang, S. -C. (2015). Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR. Oncotarget 6, 11150-11161.
107. Warren, M. S., Bradley, W. D., Gourley, S. L., Lin, Y. -C., Simpson, M. A., Reichardt, L. F., Greer, C. A., Taylor, J. R. and Koleske, A. J. (2012). Integrin beta1 signals through Arg to regulate postnatal dendritic arborization, synapse density, and behavior. J. Neurosci. 32, 2824-2834.
108. Weigel, M. T., Banerjee, S., Arnedos, M., Salter, J., A'Hern, R., Dowsett, M. and Martin, L. A. (2013). Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer. Ann. Oncol. 24, 126-133.
109. Wessler, S. and Backert, S. (2011). Abl family of tyrosine kinases and microbial pathogenesis. Int. Rev. Cell Mol. Biol. 286, 271-300.
110. Wetzel, D. M., McMahon-Pratt, D. and Koleske, A. J. (2012). The Abl and Arg kinases mediate distinct modes of phagocytosis and are required for maximal Leishmania infection. Mol. Cell. Biol. 32, 3176-3186.
111. Wong, S. and Witte, O. N. (2004). The BCR-ABL story: bench to bedside and back. Annu. Rev. Immunol. 22, 247-306.
112. Yamauchi, S., Takeuchi, K., Chihara, K., Sun, X., Honjoh, C., Yoshiki, H., Hotta, H. and Sada, K. (2015). Hepatitis C virus particle assembly involves phosphorylation of NS5A by the c-Abl tyrosine kinase. J. Biol. Chem. 290, 21857-21864.
113. Yogalingam, G. and Pendergast, A. M. (2008). Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components. J. Biol. Chem. 283, 35941-35953.
114. Zandy, N. L., Playford, M. and Pendergast, A. M. (2007). Abl tyrosine kinases regulate cell-cell adhesion through Rho GTPases. Proc. Natl. Acad. Sci. USA 104, 17686-17691.
115. Zhang, J., Adrián, F. J., Jahnke, W., Cowan-Jacob, S. W., Li, A. G., Iacob, R. E., Sim, T., Powers, J., Dierks, C., Sun, F. et al. (2010). Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature 463, 501-506.
116. Zhao, H., Ou-Yang, F., Chen, I. -F., Hou, M. -F., Yuan, S. -S. F., Chang, H. -L., Lee, Y. -C., Plattner, R., Waltz, S. E., Ho, S. -M. et al. (2010). Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer. Neoplasia 12, 214-223.
117. Zhao, H., Lo, Y. -H., Yu, L. and Wang, S. -C. (2011). Overcoming resistance to fulvestrant (ICI182, 780) by downregulating the c-ABL proto-oncogene in breast cancer. Mol. Carcinog. 50, 383-389.
118. Zipfel, P. A., Grove, M., Blackburn, K., Fujimoto, M., Tedder, T. F. and Pendergast, A. M. (2000). The c-Abl tyrosine kinase is regulated downstream of the B cell antigen receptor and interacts with CD19. J. Immunol. 165, 6872-6879.
119. Zipfel, P. A., Zhang, W., Quiroz, M. and Pendergast, A. M. (2004). Requirement for Abl kinases in T cell receptor signaling. Curr. Biol. 14, 1222-1231.